Stock UR9 CLINUVEL PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Clinuvel Pharmaceuticals Limited Deutsche Boerse AG

Equities

UR9

AU000000CUV3

Market Closed - Deutsche Boerse AG
Other stock markets
 15:35:49 2024-07-02 EDT 		5-day change 1st Jan Change
9.3 EUR -0.37% Intraday chart for Clinuvel Pharmaceuticals Limited -1.06% -6.29%
06-28 Clinuvel Pharmaceuticals Limited Announces Change of Company Secretary CI
06-24 Clinuvel Pharmaceuticals Secures Orphan Drug Designation in Europe for Metabolic Disorder Drug MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Clinuvel Pharmaceuticals Limited Announces Change of Company Secretary
CI
Clinuvel Pharmaceuticals Secures Orphan Drug Designation in Europe for Metabolic Disorder Drug
MT
Clinuvel Pharmaceuticals' Afamelanotide Found Effective in Fair-Skinned Parkinson’s Patients
MT
Afamelanotide in fair-skinned Parkinson’s patients
AQ
CLINUVEL Announces A Novel Clinical Program
CI
Clinuvel Pharmaceuticals Partners Valentech Pharma to Introduce EPP Drug in Latin America
MT
Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3%
MT
Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
AQ
Clinuvel Pharmaceuticals Launches Share Buyback Program
MT
Morgans Financial Upgrades Clinuvel Pharmaceuticals to Add From Hold; Price Target is AU$16
MT
Clinuvel Pharmaceuticals Limited announces an Equity Buyback for 1,500,000 shares, representing 2.99% of its issued share capital.
CI
Clinuvel Pharmaceuticals Limited authorizes a Buyback Plan.
CI
Malibu shines a light on CLINUVEL’s pioneering work in photomedicine
AQ
Clinuvel Reports Positive Results in SCENESSE Study
MT
Transcript : Clinuvel Pharmaceuticals Limited, H1 2024 Earnings Call, Feb 22, 2024
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Clinuvel Pharmaceuticals Limited Announces Change to Registered Office
CI
Clinuvel Doses First Patient in Phase 3 Trial of Vitiligo Treatment
MT
Transcript : Clinuvel Pharmaceuticals Limited - Special Call
Clinuvel Pharmaceuticals Limited Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CUV Stock
  4. UR9 Stock
  5. News Clinuvel Pharmaceuticals Limited